ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,107.20
      -1.02%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.505
      -0.33%
      Bitcoin
      65,865.43
      -0.09%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Castle Biosciences Inc (CSTL) Quote

      Castle Biosciences Inc

      Castle Biosciences Inc (CSTL)

      NASDAQ
      20.29
      0.39
      (1.96%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      20.29
      0.01
      (0.05%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      20.29
      Bid
      18.00
      Ask
      21.40
      Volume
      252,244
      19.525 Day's Range 20.38
      12.07 52 Week Range 25.91
      Market Cap
      560.15M
      Previous Close
      19.90
      Open
      19.59
      Last Trade
      4
      @
      20.49
      Last Trade Time
      Financial Volume
      $ 5,047,994
      VWAP
      20.0123
      Average Volume (3m)
      320,962
      Shares Outstanding
      27,607,183
      Dividend Yield
      -
      PE Ratio
      -9.74
      Earnings Per Share (EPS)
      -2.08
      Revenue
      219.79M
      Net Profit
      -57.47M

      About Castle Biosciences Inc

      Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more

      Sector
      Medical Laboratories
      Industry
      Medical Laboratories
      Website
      www.castlebiosciences.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Castle Biosciences Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CSTL. The last closing price for Castle Biosciences was $19.90. Over the last year, Castle Biosciences shares have traded in a share price range of $ 12.07 to $ 25.91.

      Castle Biosciences currently has 27,607,183 shares outstanding. The market capitalization of Castle Biosciences is $549.38 million. Castle Biosciences has a price to earnings ratio (PE ratio) of -9.74.

      Castle Biosciences (CSTL) Options Flow Summary

      CSTL Options Flow

      Overall Flow

      Bullish

      Net Premium

      308k

      Calls / Puts

      100.00%

      Buys / Sells

      100.00%

      OTM / ITM

      100.00%

      Sweeps Ratio

      0.00%

      CSTL Latest News

      More News

      Castle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of Melanoma

      Campaign will focus on empowering patients impacted by melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined...

      July 22 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      July 16 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      July 16 2024
      Edgar (US Regulatory)

      Castle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024

      Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second...

      July 15 2024
      Business Wire

      Castle Biosciences Honored with Top Workplaces Awards

      Castle earns recognition as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards Castle Biosciences, Inc. (Nasdaq:...

      July 11 2024
      Business Wire

      Recent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® Test

      Castle’s TissueCypher test has been shown to improve the risk stratification of patients with Barrett’s esophagus (BE)1,2 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health...

      June 24 2024
      Business Wire

      Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2024, the Compensation Committee of its...

      June 20 2024
      Business Wire

      Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner

      Maetzold selected as a winner of Ernst & Young’s prestigious annual awards among 48 visionary finalists in the Gulf South region, encompassing Central and South Texas, Louisiana and...

      June 14 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      June 04 2024
      Edgar (US Regulatory)

      Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance

      Castle to present a second poster on its DecisionDx®-UM test sharing data from an ongoing prospective, multi-center study of patients with uveal melanoma (UM) led by the Collaborative Ocular...

      May 30 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      11.085.6220718375819.2120.3818.738408819.50136693CS
      4-1.76-7.9818594104322.0522.1716.96539795619.29274632CS
      12-0.94-4.4276966556821.2325.9116.96532096221.71373552CS
      260.20.99552015928320.0925.9116.96527066921.65922422CS
      523.5921.49700598816.725.9112.0726871519.66143414CS
      156-48.39-70.457192778168.6878.5859.260128456225.52897787CS
      2600.291.4520107.699.260125445533.89134965CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF
       20.10
      (839.25%)
      		128.82k
      RGCRegencell Bioscience Holdings Ltd
      $ 15.15
      (349.55%)
      		1.34M
      ATPCAgape ATP Corporation
      $ 0.2262
      (58.18%)
      		107.31M
      SLRXSalarius Pharmaceuticals Inc
      $ 2.34
      (51.95%)
      		60.04M
      GSUNGolden Sun Health Technology Group Ltd
      $ 7.46
      (45.42%)
      		589.98k
      FLYEFly E Group Inc
      $ 1.1601
      (-81.82%)
      		25.44M
      RNAZTransCode Therapeutics Inc
      $ 0.3035
      (-61.70%)
      		9.78M
      JAGXJaguar Health Inc
      $ 1.755
      (-58.90%)
      		15.47M
      MIRAMIRA Pharmaceuticals Inc
      $ 2.55
      (-49.10%)
      		25.64M
      IVPInspire Veterinary Partners Inc
      $ 5.19
      (-43.83%)
      		1.67M
      SLNASelina Hospitality PLC
      $ 0.026
      (-29.73%)
      		220.18M
      SPWRSunPower Corporation
      $ 0.9514
      (32.91%)
      		186.75M
      NVDANVIDIA Corporation
      $ 122.59
      (-0.77%)
      		173.87M
      ADILAdial Pharmaceuticals Inc
      $ 1.3422
      (26.62%)
      		160.04M
      HOLOMicroCloud Hologram Inc
      $ 0.588
      (26.07%)
      		135.53M

      Discussion

      View Full Feed
      waterchaser waterchaser 5 minutes ago
      How’ the puff VNUE promo going so far?
      VNUE
      Lime Time Lime Time 5 minutes ago
      100% correct. But if you hit the winner tickers at the right time, it gives the best return on investment.
      ZRFY
      dukeb dukeb 6 minutes ago
      The OTC is a cesspool. 90%+ of what trades there are companies that will never show a profit.

      Shares trade amongst a group of people who are playing a game of musical chairs, hoping they aren't the one left without a seat but with the addition of people who generate chatter hoping to
      ZRFY
      MightyX MightyX 6 minutes ago
      You’re only laughing at yourself
      TPTW
      VeronicaFox VeronicaFox 6 minutes ago
      Interesting they were never PRd in a new release. The ale isnt making traders any money. Doubt it ever will. Traders know it’s always all about the stock, but you’d rather promote it.

      KEGS = 10,800,000,000 Outstanding shares

      KEGS = $226 total dollar volume today.
      KEGS
      waterchaser waterchaser 7 minutes ago
      It’s painful to watch-scam-pumpers go down in smoke.
      (or not)
      SIPC
      Huggy Bear Huggy Bear 7 minutes ago
      That's a FACT.
      ZRFY
      conix conix 8 minutes ago
      It is very obvious that with the deleted messages and obvious censorship here that I do not control this board. The bias is obvious and is set up to be an echo chamber. However, when a non-Leftist appears, the activity on the board goes up and there is more entertaining posts than the boring cut and
      dukeb dukeb 8 minutes ago
      The OTC is a cesspool. 90%+ of what trades there are companies that will never show a profit.

      Shares trade amongst a group of people who are playing a game of musical chairs, hoping they aren't the one left without a seat but with the addition of people who generate chatter hoping to
      ZRFY
      catdaddy catdaddy 8 minutes ago
      Took a long time to respond, didn’t it? Makes me think you two are one in the same.
      AVXL
      Golden Cross Golden Cross 8 minutes ago
      $NBRI North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton
      https://app.mininghub.com/?id=65487&pid=8022&ogid=9802
      NBRI
      Golden Cross Golden Cross 9 minutes ago
      $NBRI North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton
      https://app.mininghub.com/?id=65487&pid=8022&ogid=9802
      NBRI
      SSKILLZ1 SSKILLZ1 9 minutes ago
      everytime you go to ottovino he gives up runs. everytime. He is simply done. DFA him. I would of brought alex youngin. He probably stinks, but anything has to be better than adam otto stinko.
      janice shell janice shell 11 minutes ago
      LOLOLOLOLOLOLISSIMO!!
      Funaboard Funaboard 12 minutes ago
      Again I do not know ...
      KATX
      newmedman newmedman 12 minutes ago
      Do me and everyone here a favor and leave this board. You are not open to reading anything any point of view you do not subscribe to.

      Couldn't have said it better myself. It's definitely time for you to step down. When you start to find yourself posting media from foreign countries w
      Lime Time Lime Time 12 minutes ago
      Write to your legislators. This is all legal. They did 5 reverse splits and FINRA put it through. Very disgusting. Attack FINRA
      ZRFY
      Swammmie1040 Swammmie1040 12 minutes ago
      Not a chart guy for otc but they won’t hurt ya .i hit Hiru at the right time lol, good luck to you ….
      RONN
      timberwolf7 timberwolf7 12 minutes ago
      Naw zab, its only 'fake news' to you commie supporters cause you

      hate HONESTY, the TRUTH..

      Speaks volumes for WHO YOU ARE, your own character..

      Pretty ugly picture you are presenting of yourself and you are too

      stupid to see/know it..
      m$teamworkotc m$teamworkotc 12 minutes ago
      GlobeStar is focused on efforts to obtain regulatory approvals for, and then commercialize, Project Amethyst™. Project Amethyst™ is a compound intended to treat neurodegeneration from MS, consisting of a patented custom drug cocktail of Minocycline, Fluconazole, and Atorvastatin. Each of these drugs
      GSTC
      m$teamworkotc m$teamworkotc 12 minutes ago
      GlobeStar is focused on efforts to obtain regulatory approvals for, and then commercialize, Project Amethyst™. Project Amethyst™ is a compound intended to treat neurodegeneration from MS, consisting of a patented custom drug cocktail of Minocycline, Fluconazole, and Atorvastatin. Each of these drugs
      GSTC
      BoscoLives21 BoscoLives21 13 minutes ago
      Yes they did win those four awards! Which indicates they are achieving milestones and becoming more popular and established. Won’t be able to hold this company down much longer!
      $KEGS
      KEGS
      georgejjl georgejjl 14 minutes ago
      Doc328: Do you believe that the following is in general true or false???
      Alzheimer's disease is easier to treat at the earliest stage possible. See the image below to understand why this is true.


      The above is especially true if you are targeting upstream MOA with precis
      AVXL
      bull runs bull runs 14 minutes ago
      In a clip from five years ago, Kamala Harris told CNN's Jake Tapper that she supports universal healthcare, including Medicare for illegals!

      As Border Czar, Kamala allowed 10 million+ illegals to invade America and she would ensure they all get free stuff at taxpayers' expense.

      Your Recent History

      NASDAQ
      CSTL
      Castle Biosciences
      LSE
      GNS
      Genus
      LSE
      IVPG
      Invesco Select
      TSXV
      SEB
      Smart Employee Benefits
      Delayed Upgrade Clock